explore -WSS

explore

author：entertainment 2025-08-26 10:52:27 - browse：84122

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： A solution to the after

WSS

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

In 'major milestone,' FDA approves first cell therapy for solid tumors

New documents shed light on MD Anderson Cancer Institute feud

PBM reform efforts get punted in Congress

New CMS data security rules will hurt Medicare, Medicaid research

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

entertainment

explore

hotspot

New air purifier tech could be key to improving indoor air quality

The Harvard botanist who searched for psychedelics in the Amazon

Guidelines to prevent youth baseball injuries need more muscle

He's a Nobel laureate. Critics say he was misleading on Covid

The cancer drug shortage isn’t new — and neither are the solutions

In 'major milestone,' FDA approves first cell therapy for solid tumors

DIEP, the 'gold standard' of breast reconstruction, is under threat

Obamacare plans could cover weight loss drugs

Affirmative action in medical school literally saved lives

Congress may force more Covid

focus

Alabama hospital puts IVF treatments on hold

A solution to the after

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

knowledge

focus

focus

focus